1356840-08-8
1356840-08-8
Chemical Structure
Moexiprilat-d5
- CAS. Nr.: 1356840-08-8
- Formula:C25H25D5N2O7
- Molecular Weight:475.55
IUPAC Name: (S)-2-(((S)-1-carboxy-3-(phenyl-d5)propyl)-L-alanyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
InChIKey: CMPAGYDKASJORH-XKCVKMNPSA-N
SMILES: O=C([C@H]1N(C([C@@H](N[C@H](C(O)=O)CCC2=C([2H])C([2H])=C([2H])C([2H])=C2[2H])C)=O)CC3=C(C=C(OC)C(OC)=C3)C1)O
Biological Activity: Moexiprilat-d5 is deuterium labeled Moexiprilat.
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Moexiprilat-d5 | Moexiprilat-d5 is deuterium labeled Moexiprilat. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Moexiprilat | Moexiprilat is an inhibitor of angiotensin-converting enzyme (ACE; IC50=2.1 nM) and an active metabolite of the prodrug Moexipril (HY-117281). It is formed from moexipril in vivo by side chain ester hydrolysis. Moexiprilat (10 nM) prevents the estrone- or angiotensin II-stimulated proliferation of primary neonatal rat cardiac fibroblasts. It reduces mean arterial blood pressure and increases the levels of atrial natriuretic peptide, a marker of hypertension, in ovariectomized mice when administered at a dose of 50 mg/kg per day. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
